Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€1.42
11.07.22
€1.00
11.07.23
-62.68%
12.07.23

buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€0.83
11.01.23
€1.00
11.01.24
-37.36%
24.06.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Mandalay Resources Corp.

Start price
Target price
Perf. (%)
€1.16
19.06.23
-
19.06.24
2.94%
24.06.23

Could be very worthwhile Investment >20% year
buy
Nevada Copper Corp.

Start price
Target price
Perf. (%)
€0.23
19.06.22
-
19.06.23
-38.58%
19.06.23

buy
Lithium Americas Corp.

Start price
Target price
Perf. (%)
€20.12
13.06.22
€28.00
13.06.23
-2.71%
14.06.23

buy
Lithium Chile Inc.

Start price
Target price
Perf. (%)
€0.61
09.06.23
-
09.07.23
11.51%
12.06.23

buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€3.77
11.06.22
€3.30
11.06.23
-23.61%
12.06.23

EBIT growth >5% per year expected
Revenue growth >5% per year expected
Fair valuation
Lower EBIT Margin than peer group
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€3.60
16.04.23
-
16.04.24
-16.11%
30.05.23

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.22
11.03.23
€4.60
11.03.24
18.48%
19.05.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.87
24.03.23
-
24.03.24
12.58%
18.05.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.55
03.01.23
-
03.01.24
78.44%
14.05.23

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.86
27.10.21
€40.00
31.12.23
-59.32%
08.05.23

Could be very worthwhile Investment >20% year
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
18.10.21
€12.00
31.12.23
-2.68%
08.05.23

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.49
10.10.21
€5.00
31.12.23
-32.83%
08.05.23

Could be very worthwhile Investment >20% year
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€1.17
23.10.22
€1.30
23.10.23
-48.66%
06.05.23

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.46
04.01.23
€12.00
31.12.25
63.49%
05.05.23

Could be very worthwhile Investment >20% year
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.23
28.05.22
-
28.05.23
-56.27%
24.04.23

Probably not worthwhile Investment
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€36.73
11.03.23
€30.00
11.03.24
0.48%
18.04.23

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.34
12.09.22
-
12.09.23
-93.70%
02.04.23

Could be very worthwhile Investment >20% year
buy
Excellon Resources Inc

Start price
Target price
Perf. (%)
€0.77
27.03.22
-
27.03.23
-64.08%
27.03.23

Risky Investment
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.30
20.03.23
-
20.03.24
6.18%
23.03.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
buy
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€26.85
14.03.22
€40.00
14.03.23
36.78%
11.03.23

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.37
21.07.22
€5.30
21.07.23
-21.42%
11.03.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Fission Uranium Corp.

Start price
Target price
Perf. (%)
€0.62
26.02.22
-
26.02.23
-10.97%
27.02.23